Development and validation of a patient-reported outcome measure for hair loss treatment: The HAIR-Q.

Rasch analysis aesthetic medicine hair loss patient‐reported outcome psychometric

Journal

Journal of cosmetic dermatology
ISSN: 1473-2165
Titre abrégé: J Cosmet Dermatol
Pays: England
ID NLM: 101130964

Informations de publication

Date de publication:
16 Jul 2024
Historique:
revised: 20 06 2024
received: 05 01 2024
accepted: 03 07 2024
medline: 16 7 2024
pubmed: 16 7 2024
entrez: 16 7 2024
Statut: aheadofprint

Résumé

Patient-reported outcome measures (PROMs) for hair loss focus mainly on Alopecia Areata. We created a PROM (i.e., HAIR-Q) that is applicable to any hair loss condition. The HAIR-Q measures satisfaction with hair. Concept elicitation interviews were conducted and analyzed to develop a draft scale. Content validity was established through multiple rounds of patient and expert input. Psychometric properties of the scale were examined in an online sample (i.e., Prolific) using Rasch measurement theory (RMT) analysis. Test-retest reliability and tests of construct validation were examined. Content validity of a 22-item draft scale was established with input from 11 patients, 12 experts and an online Prolific sample of 59 people who had a variety of hair loss treatments. In the RMT analysis (n = 390), 8 items were dropped. Data for the 14-item scale fit the Rasch model (χ The HAIR-Q evidenced reliability and validity and can be used in research and to inform clinical care to measure satisfaction with hair from the patient perspective.

Sections du résumé

BACKGROUND BACKGROUND
Patient-reported outcome measures (PROMs) for hair loss focus mainly on Alopecia Areata. We created a PROM (i.e., HAIR-Q) that is applicable to any hair loss condition. The HAIR-Q measures satisfaction with hair.
PATIENTS/METHODS METHODS
Concept elicitation interviews were conducted and analyzed to develop a draft scale. Content validity was established through multiple rounds of patient and expert input. Psychometric properties of the scale were examined in an online sample (i.e., Prolific) using Rasch measurement theory (RMT) analysis. Test-retest reliability and tests of construct validation were examined.
RESULTS RESULTS
Content validity of a 22-item draft scale was established with input from 11 patients, 12 experts and an online Prolific sample of 59 people who had a variety of hair loss treatments. In the RMT analysis (n = 390), 8 items were dropped. Data for the 14-item scale fit the Rasch model (χ
CONCLUSION CONCLUSIONS
The HAIR-Q evidenced reliability and validity and can be used in research and to inform clinical care to measure satisfaction with hair from the patient perspective.

Identifiants

pubmed: 39013033
doi: 10.1111/jocd.16465
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 The Author(s). Journal of Cosmetic Dermatology published by Wiley Periodicals LLC.

Références

Al Aboud AM, Zito PM. Alopecia. StatPearls [Internet]. StatPearls Publishing; 2023 [Accessed April 16, 2023]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK538178/
https://www.aad.org/public/diseases/hair‐loss/causes/18‐causes
Dhami L. Psychology of hair loss patients and importance of counseling. Indian J Plast Surg. 2021;54(4):411‐415. doi:10.1055/s-0041-1741037
Moattari CR, Jafferany M. Psychological aspects of hair disorders: consideration for dermatologists, cosmetologists, aesthetic, and plastic surgeons. Skin Appendage Disord. 2022;8(3):186‐194.
Schmitt JV, Ribeiro CF, Souza FH, Siqueira EB, Bebber FR. Hair loss perception and symptoms of depression in female outpatients attending a general dermatology clinic. An Bras Dermatol. 2012;87:412‐417.
Hunt N, McHale S. The psychological impact of alopecia. BMJ. 2005;331(7522):951‐953.
Ahluwalia J, Fabi SG. The psychological and aesthetic impact of age‐related hair changes in females. J Cosmet Dermatol. 2019;18(4):1161‐1169.
Hadshiew IM, Foitzik K, Arck PC, Paus R. Burden of hair loss: stress and the underestimated psychosocial impact of telogen effluvium and androgenetic alopecia. J Invest Dermatol. 2004;123(3):455‐457.
Alfonso M, Richter‐Appelt H, Tosti A, Viera MS, García M. The psychosocial impact of hair loss among men: a multinational European study. Curr Med Res Opin. 2005;21(11):1829‐1836.
Aldhouse NV, Kitchen H, Knight S, et al. “‘You lose your hair, what's the big deal?’I was so embarrassed, I was so self‐conscious, I was so depressed:” a qualitative interview study to understand the psychosocial burden of alopecia areata. J Patient Rep Outcomes. 2020;4(1):1‐2.
Cash TF. The psychology of hair loss and its implications for patient care. Clin Dermatol. 2001;19(2):161‐166.
Poot F. Psychological consequences of chronic hair diseases. Rev Med Brux. 2004;25(4):A286‐A288.
Farrant P, McHale S. Psychological impact of hair loss. Pract Psychodermatol. 2014;20:79‐89.
Mohamed NE, Soltan MR, Galal SA, El Sayed HS, Hassan HM, Khatery BH. Female pattern hair loss and negative psychological impact: possible role of brain‐derived neurotrophic factor (BDNF). Dermatol Pract Concept. 2023;13(3):e2023139. doi:10.5826/dpc.1303a139
Meyers A, Jin A, Kwiecien GJ, Gatherwright J, Khetarpal S, Zins JE. Platelet‐rich plasma for treatment of hair loss improves patient‐reported quality of life. Aesth Plast Surg. 2023;13:1‐7.
Zhuang XS, Zheng YY, Xu JJ, Fan WX. Quality of life in women with female pattern hair loss and the impact of topical minoxidil treatment on quality of life in these patients. Exp Ther Med. 2013;6(2):542‐546.
Squitieri L, Bozic KJ, Pusic AL. The role of patient‐reported outcome measures in value‐based payment reform. Value Health. 2017;20(6):834‐836.
Meadows KA. Patient‐reported outcome measures: an overview. Br J Community Nurs. 2011;16(3):146‐151.
Food and Drug Administration. Guidance for industry patient‐reported outcome measures: use in medical product development to support labeling claims. Silver Spring, MD. 2009. Accessed: May 20, 2023 https://www.fda.gov/downloads/drugs/guidances/ucm193282.pdf
Mokkink LB, Prinsen CA, Patrick DL, et al. COSMIN Study Design Checklist for Patient‐Reported Outcome Measurement Instruments. The Netherlands; 2019:1‐32.
Prinsen CA, Mokkink LB, Bouter LM, et al. COSMIN guideline for systematic reviews of patient‐reported outcome measures. Qual Life Res. 2018;27:1147‐1157.
Terwee CB, Prinsen CA, Chiarotto A, et al. COSMIN methodology for evaluating the content validity of patient‐reported outcome measures: a Delphi study. Qual Life Res. 2018;27:1159‐1170.
Meadows K. Patient‐reported outcome measures: an overview. Br J Community Nurs. 2011;16:146‐151.
Arguelles G, Shin M, Lebrun D, Kocher M, Baldwin K, Patel N. The majority of patient‐reported outcome measures in pediatric Orthopaedic research are used without validation. J Pediatr Orthop. 2021;41(1):e74‐e79. doi:10.1097/BPO.0000000000001659
Xia E, Li SJ, Drake L, et al. An assessment of current clinician‐reported and patient‐reported outcome measures for alopecia Areata: a scoping review. J Invest Dermatol. 2023;143:1133‐1137. e12.
Wyrwich KW, Kitchen H, Knight S, et al. Development of the scalp hair assessment PRO™ measure for alopecia areata. Br J Dermatol. 2020;183(6):1065‐1072. doi:10.1111/bjd.19024
Mendoza TR, Osei JS, Shi Q, Duvic M. Development of the alopecia areata symptom impact scale. J Investig Dermatol Symp Proc. 2013;16(1):S51‐S52.
Fabbrocini G, Panariello L, De Vita V, et al. Quality of life in alopecia areata: a disease‐specific questionnaire. J Eur Acad Dermatol Venereol. 2013;27:e276.
Chren MM. The Skindex instruments to measure the effects of skin disease on quality of life. Dermatol Clin. 2012;30(2):231‐236. doi:10.1016/j.det.2011.11.003
Han SH, Byun JW, Lee WS, et al. Quality of life assessment in male patients with androgenetic alopecia: result of a prospective Multicenter Study. Ann Dermatol. 2012;24(3):311‐318.
Barber BI, Kaufman KD, Kozloff RC, Girman CJ, Guess HA. A hair growth questionnaire for use in the evaluation of therapeutic effects in men. J Dermatol Treat. 1998;9(3):181‐186.
Hobart J, Cano S. Improving the evaluation of therapeutic interventions in multiple sclerosis: the role of new psychometric methods. Health Technol Assess. 2009;2009:214.
Klassen AF, Pusic A, Kaur M, et al. The SKIN‐Q: an innovative patient‐reported outcome measure for evaluating minimally invasive skin treatments for the face and body. Facial Plast Surg Aesthet Med. 2024;26(3):247‐255. doi:10.1089/fpsam.2023.0204
Klassen AF, Pusic A, Kaur M, et al. Extending the range of measurement for minimally invasive treatments by adding new concepts to FACE‐Q aesthetics scales. Plast Reconstr Surg Glob Open. 2024;12(4):e5736. doi:10.1097/GOX.0000000000005736
Patrick DL, Burke LB, Gwaltney CJ, et al. Content validity—establishing and reporting the evidence in newly developed patient‐reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1—eliciting concepts for a new PRO instrument. Value Health. 2011;14(8):967‐977.
Thorne S, Kirkham SR, MacDonald‐Emes J. Interpretive description: a noncategorical qualitative alternative for developing nursing knowledge. Res Nurs Health. 1997;20(2):169‐177.
Pope C, Ziebland S, Mays N. Qualitative research in health care analysing qualitative data. Br Med J. 2000;320(7227):114‐116.
Sandelowski M. Theoretical saturation. In: Given LM, ed. The Sage Encyclopedia of Qualitative Methods. Vol 1. Sage; 2008:875‐876.
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata‐driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377‐381.
Rasch G. Studies in mathematical psychology: I. Probabilistic Models for some Intelligence and Attainment Tests. 1960.
Andrich D, Sheridan BS, Luo G. RUMM2030Plus: Rasch Unidimensional Models for Measurement. RUMM Laboratory; 2021. [Accessed: October 10, 2023]. www.rummlab.com.au
Christensen KB, Makransky G, Horton M. Critical values for Yen's Q 3: identification of local dependence in the rasch model using residual correlations. Appl Psychol Meas. 2017;41(3):178‐194.
Cleanthous S, Bongardt S, Marquis P, Stach C, Cano S, Morel T. Psychometric analysis from EMBODY1 and 2 clinical trials to help select suitable fatigue pro scales for future systemic lupus erythematosus studies. Rheumatol Ther. 2021;8(3):1287‐1301.
Andrich D, Hagquist C. Real and artificial differential item functioning. J Educ Behav Stat. 2012;37(3):387‐416.
Andrich D. An index of person separation in latent trait theory, the traditional KR.20 index, and the Guttman scale response pattern. Educ Res Perspect. 1982;9(1):95‐104. Mary Ann Liebert, Inc. Page 22 of 49.
Nunnally JC. Psychometric Theory. 3rd ed. McGraw‐Hill; 1994.
Kim HY. Statistical notes for clinical researchers: Assessing normal distribution (2) using skewness and kurtosis. Restor Dent Endod. 2013;38(1):52‐54. doi:10.5395/rde.2013.38.1.52
McKenna SP, Heaney A, Wilburn J, Stenner AJ. Measurement of patient‐reported outcomes. 1: the search for the holy grail. J Med Econ. 2019;22(6):516‐522.
Mokkink LB, Terwee CB, Patrick DL, et al. COSMIN Checklist Manual. University Medical Center; 2012.
McAllister S. Introduction to the use of Rasch analysis to assess patient performance. Int J Ther Rehabil. 2008;15(11):482‐490.
Nelson EC, Eftimovska E, Lind C, Hager A, Wasson JH, Lindblad S. Patient reported outcome measures in practice. BMJ. 2015;10:350.
Browne JP, Cano SJ, Smith S. Using patient‐reported outcome measures to improve health care. Med Care. 2017;55(10):901‐904.
Black N. Patient reported outcome measures could help transform healthcare. BMJ. 2013;28(346):f167. doi:10.1136/bmj.f167
Damman OC, Jani A, de Jong BA, et al. The use of PROMs and shared decision‐making in medical encounters with patients: an opportunity to deliver value‐based health care to patients. J Eval Clin Pract. 2020;26(2):524‐540.
Ruseckaite R, Maharaj AD, Krysinska K, Dean J, Ahern S. Developing a preliminary conceptual framework for guidelines on inclusion of patient reported‐outcome measures (PROMs) in clinical quality registries. Patient Relat Outcome Meas. 2019;10:355‐372.
Prodinger B, Taylor P. Improving quality of care through patient‐reported outcome measures (PROMs): expert interviews using the NHS PROMs Programme and the Swedish quality registers for knee and hip arthroplasty as examples. BMC Health Serv Res. 2018;18:1‐3.
Mercieca‐Bebber R, King MT, Calvert MJ, Stockler MR, Friedlander M. The importance of patient‐reported outcomes in clinical trials and strategies for future optimization. Patient Relat Outcome Meas. 2018;1:353‐367.
Peer E, Rothschild D, Gordon A, Evernden Z, Damer E. Data quality of platforms and panels for online behavioral research. Behav Res Methods. 2022;54(4):1643‐1662.
Douglas BD, Ewell PJ, Brauer M. Data quality in online human‐subjects research: comparisons between MTurk, prolific, CloudResearch, Qualtrics, and SONA. PLoS One. 2023;18(3):e0279720. doi:10.1371/journal.pone.0279720

Auteurs

Anne F Klassen (AF)

Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.

Jasmine Mansouri (J)

Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.

Manraj Kaur (M)

Department of Surgery, Patient Reported Outcome, Value, and Experience (PROVE) Center, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Charlene Rae (C)

Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.

Lotte Poulsen (L)

Research Unit for Plastic Surgery, Odense University Hospital, Odense, Denmark.
Løntoft, Nyhøj and Poulsen Plastic Surgery, Odense, Denmark.

Steven Dayan (S)

Dayan Facial Plastic Surgery, Chicago, Illinois, USA.

Stefan J Cano (SJ)

Modus Outcomes (A Division of Thread), Cheltenham, UK.

Andrea L Pusic (AL)

Department of Surgery, Patient Reported Outcome, Value, and Experience (PROVE) Center, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Classifications MeSH